Evaluation of a Novel Telemedicine Clinic for Patients With DM2 on Multiple Daily Insulin (MDI) Regimens
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Almost 40% of veterans have diabetes, the proposed research may improve clinical care among veterans with diabetes. In this application we are going to examine whether utilizing Smart Insulin pens (SIPs) with CGMs and telemedicine is a better tool for managing diabetes compared to traditional insulin pens, CGMs and telemedicine, leading to improved blood sugar control and better clinical outcomes.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• ≥18 years of age
• MDI insulin treated (receiving MDI for at least 3 months prior to the study)
Locations
United States
Maryland
Baltimore VA Maryland Center
RECRUITING
Baltimore
VAMHCS, Diabetes Outpatient Clinic
NOT_YET_RECRUITING
Baltimore
Contact Information
Primary
William Scott, MS
william.scott5@va.gov
4106057000
Time Frame
Start Date: 2026-01-30
Estimated Completion Date: 2028-05-30
Participants
Target number of participants: 50
Treatments
Experimental: Intervention Group
Intervention group: will be managed with telehealth and InPen Smart insulin pens
Other: Control Group
Control group: will be managed by telehealth and the traditional/standard insulin pen (widely used)
Related Therapeutic Areas
Sponsors
Collaborators: Medtronic
Leads: University of Maryland, Baltimore